DZ2311A1 - Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. - Google Patents

Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives.

Info

Publication number
DZ2311A1
DZ2311A1 DZ970161A DZ970161A DZ2311A1 DZ 2311 A1 DZ2311 A1 DZ 2311A1 DZ 970161 A DZ970161 A DZ 970161A DZ 970161 A DZ970161 A DZ 970161A DZ 2311 A1 DZ2311 A1 DZ 2311A1
Authority
DZ
Algeria
Prior art keywords
preparation
degenerative diseases
benzopyran derivatives
medicaments against
against degenerative
Prior art date
Application number
DZ970161A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2311A1 publication Critical patent/DZ2311A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DZ970161A 1996-09-18 1997-09-17 Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. DZ2311A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment

Publications (1)

Publication Number Publication Date
DZ2311A1 true DZ2311A1 (fr) 2002-12-28

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970161A DZ2311A1 (fr) 1996-09-18 1997-09-17 Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives.

Country Status (30)

Country Link
EP (1) EP0939630B1 (fr)
JP (1) JP2001500520A (fr)
KR (1) KR20000036184A (fr)
CN (1) CN1230885A (fr)
AP (1) AP9901473A0 (fr)
AR (1) AR008838A1 (fr)
AT (1) ATE270102T1 (fr)
AU (1) AU730465B2 (fr)
BG (1) BG103252A (fr)
BR (1) BR9712030A (fr)
CA (1) CA2266681A1 (fr)
DE (1) DE69729735T2 (fr)
DZ (1) DZ2311A1 (fr)
EA (1) EA199900306A1 (fr)
ES (1) ES2223075T3 (fr)
GB (1) GB9619492D0 (fr)
HU (1) HUP9904638A3 (fr)
ID (2) ID23175A (fr)
IL (1) IL128786A0 (fr)
MA (1) MA24321A1 (fr)
NO (1) NO991292L (fr)
NZ (1) NZ334271A (fr)
OA (1) OA10998A (fr)
PE (1) PE109898A1 (fr)
PL (1) PL332313A1 (fr)
SK (1) SK35199A3 (fr)
TR (1) TR199900527T2 (fr)
UY (1) UY24717A1 (fr)
WO (1) WO1998011890A1 (fr)
ZA (1) ZA978359B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
CA2726878A1 (fr) * 2008-06-05 2009-12-10 Minster Research Limited Nouveaux traitements
WO2009147441A2 (fr) * 2008-06-05 2009-12-10 Minster Research Limited Nouveaux traitements
WO2011067607A1 (fr) * 2009-12-03 2011-06-09 Minster Research Ltd Traitement de maladies infectieuses
HUE034911T2 (hu) 2009-07-27 2018-03-28 Gilead Sciences Inc Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
EP2506846A1 (fr) * 2009-12-03 2012-10-10 Proximagen Limited Traitement de l'allodynie et de l'hyperalgésie
EP2588197B1 (fr) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Composés hétérocycliques condensés en tant que modulateurs des canaux ioniques
WO2012154760A1 (fr) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Composés hétérocycliques condensés utilisés comme modulateurs des canaux sodiques
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
NO3175985T3 (fr) 2011-07-01 2018-04-28
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham P.L.C., Brentford Benzopyrans und deren verwendung als therapeutische mittel

Also Published As

Publication number Publication date
IL128786A0 (en) 2000-01-31
AU4704797A (en) 1998-04-14
JP2001500520A (ja) 2001-01-16
NO991292D0 (no) 1999-03-17
UY24717A1 (es) 2001-08-27
MA24321A1 (fr) 1998-04-01
DE69729735D1 (de) 2004-08-05
BR9712030A (pt) 1999-08-24
OA10998A (en) 2003-03-04
TR199900527T2 (xx) 1999-06-21
PE109898A1 (es) 1999-03-21
CN1230885A (zh) 1999-10-06
DE69729735T2 (de) 2005-07-14
ID23175A (id) 2000-03-23
AU730465B2 (en) 2001-03-08
NZ334271A (en) 2001-03-30
ATE270102T1 (de) 2004-07-15
CA2266681A1 (fr) 1998-03-26
GB9619492D0 (en) 1996-10-30
AR008838A1 (es) 2000-02-23
SK35199A3 (en) 2000-07-11
WO1998011890A1 (fr) 1998-03-26
HUP9904638A3 (en) 2001-08-28
ZA978359B (en) 1999-03-17
PL332313A1 (en) 1999-08-30
BG103252A (en) 1999-09-30
HUP9904638A2 (hu) 2001-05-28
EP0939630B1 (fr) 2004-06-30
KR20000036184A (ko) 2000-06-26
NO991292L (no) 1999-03-17
AP9901473A0 (en) 1999-03-31
ES2223075T3 (es) 2005-02-16
EA199900306A1 (ru) 1999-08-26
ID19542A (id) 1998-07-23
EP0939630A1 (fr) 1999-09-08

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
AP9901677A0 (en) Substituted benzopyran derivatives for the treatment of inflammation
ATE255117T1 (de) Aminophosphonsäure-derivate als arzneimittel
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
MX15184A (es) Procedimiento para la preparacion de derivados de isoindolinona,compuesto obtenido y medicamento quelo incluye.
AU7000796A (en) Heteroaryl-substituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
DZ2308A1 (fr) Procédés et intermédiaires pour la préparation de dérivés de chromanol substitués.
HUP0003398A3 (en) Novel triptolide derivatives and pharmaceutical compositions thereof
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
HUP0004648A3 (en) 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU8553898A (en) Use of 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions to treat diseases connected with the endogenous opioid system
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
ZA97872B (en) Use of pyrolidine derivatives for the manufacture of medicaments.
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU6582098A (en) Medical splint product
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
HUP0000966A3 (en) Isoflavone derivatives and pharmaceutical compositions containing them
HU9802500D0 (en) Pocess for the preparation of periodates
IL127690A0 (en) Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them